Personalizing treatment selection in Crohn’s disease: a meta-analysis of individual participant data from fifteen randomized controlled trials

BACKGROUND: Meta-analyses have found anti-TNF drugs to be the best treatment, on average, for Crohn’s disease. We performed a subgroup analysis to determine if it is possible to achieve more efficacious outcomes by individualizing treatment selection. METHODS: We obtained participant-level data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudrapatna, Vivek A., Ravindranath, Vignesh G., Arneson, Douglas V., Mosenia, Arman, Butte, Atul J., Wang, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659518/
https://www.ncbi.nlm.nih.gov/pubmed/37986977
http://dx.doi.org/10.1101/2023.11.10.23291837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659518/
https://www.ncbi.nlm.nih.gov/pubmed/37986977
http://dx.doi.org/10.1101/2023.11.10.23291837

Ejemplares similares